Liesa DeNardo
Plus aucun poste en cours
Profil
Liesa DeNardo worked as a Principal at PharmaGenics, Inc. and as an Administration Manager at Collagen Matrix, Inc. from 1999 to 2013.
She obtained an undergraduate degree from Eastern University.
Anciens postes connus de Liesa DeNardo
| Sociétés | Poste | Fin |
|---|---|---|
PharmaGenics, Inc.
 PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services PharmaGenics, Inc. develops therapeutic products for cancer. The American company was founded by Mike I. Sherman. PharmaGenics was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on June 18, 1997 for $112 million. | Corporate Officer/Principal | - |
Collagen Matrix, Inc.
 Collagen Matrix, Inc. Medical SpecialtiesHealth Technology Collagen Matrix, Inc. design and manufactures extracellular matrices for tissue and organ repair and regeneration. The firm offers collagen and mineral-based finished medical devices in the areas of orthopedic-spine surgery, neurosurgery, oral surgery, and wound care. It provides DuraMatrix, Neuroflex, NeuroMatrix, OssiMend, and the Matrix Collagen. The company was founded by Shu-Tung Li in 1997 and is headquartered in Oakland, NJ. | Directeur Administratif | - |
Formation de Liesa DeNardo
| Eastern University | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Collagen Matrix, Inc.
Collagen Matrix, Inc. Medical SpecialtiesHealth Technology Collagen Matrix, Inc. design and manufactures extracellular matrices for tissue and organ repair and regeneration. The firm offers collagen and mineral-based finished medical devices in the areas of orthopedic-spine surgery, neurosurgery, oral surgery, and wound care. It provides DuraMatrix, Neuroflex, NeuroMatrix, OssiMend, and the Matrix Collagen. The company was founded by Shu-Tung Li in 1997 and is headquartered in Oakland, NJ. | Health Technology |
PharmaGenics, Inc.
PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services PharmaGenics, Inc. develops therapeutic products for cancer. The American company was founded by Mike I. Sherman. PharmaGenics was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on June 18, 1997 for $112 million. | Commercial Services |
